[1]Fadda A, Butt F, Tomei S, et al. Two hits in one: whole genome sequencing unveils LIG4 syndrome and urofacial syndrome in a case report of a child with complex phenotype[J]. BMC Med Genet, 2016,17:84. [2]Tilgner K, Neganova I, Moreno-Gimeno I, et al. A human iPSC model of Ligase Ⅳ deficiency reveals an important role for NHEJ-mediated-DSB repair in the survival and genomic stability of induced pluripotent stem cells and emerging haematopoietic progenitors[J]. Cell Death Differ, 2013,20:1089-1100. [3]Dudley DD, Chaudhuri J, Bassing CH, et al. Mechanism and control of V(D)J recombination versus class switch recombination: similarities and differences[J]. Adv Immunol, 2005,86:43-112. [4]Holthausen JT, Wyman C, Kanaar R. Regulation of DNA strand exchange in homologous recombination[J]. DNA Repair (Amst), 2010,9:1264-1272. [5]Jiang J, Tang W, An Y, et al. Molecular and immunological characterization of DNA ligase Ⅳ deficiency[J]. Clin Immunol, 2016,163:75-83. [6]越桐, 李建国, 周志轩, 等. LIG4综合征四例并文献复习[J]. 中华儿科杂志, 2019,3:217-221. [7]钟舒文, 蒋丽蓉, 邓朝晖, 等. LIG4基因突变导致慢性腹泻1例报告并文献复习[J]. 临床儿科杂志, 2019,4:308-311,320. [8]Murray JE, Bicknell LS, Yigit G, et al. Extreme growth failure is a common presentation of ligase Ⅳ deficiency[J]. Hum Mutat, 2014,35:76-85. [9]IJspeert H, Warris A, van der Flier M, et al. Clinical spectrum of LIG4 deficiency is broadened with severe dysmaturity, primordial dwarfism, and neurological abnormalities[J]. Hum Mutat, 2013,34:1611-1614. [10]O'Driscoll M, Cerosaletti KM, Girard PM, et al. DNA ligase Ⅳ mutations identified in patients exhibiting developmental delay and immunodeficiency[J]. Mol Cell, 2001,8:1175-1185. [11]Enders A, Fisch P, Schwarz K, et al. A severe form of human combined immunodeficiency due to mutations in DNA ligase Ⅳ[J]. J Immunol, 2006,176:5060-5068. [12]Lieber MR, Ma Y, Pannicke U, et al. Mechanism and regulation of human non-homologous DNA end-joining[J]. Nat Rev Mol Cell Biol, 2003,4:712-720. [13]van der Burg M, van Veelen LR, Verkaik NS, et al. A new type of radiosensitive T-B-NK+ severe combined immunodeficiency caused by a LIG4 mutation[J]. J Clin Invest, 2006,116:137-145. [14]Rucci F, Notarangelo LD, Fazeli A, et al. Homozygous DNA ligase Ⅳ R278H mutation in mice leads to leaky SCID and represents a model for human LIG4 syndrome[J]. Proc Natl Acad Sci U S A, 2010,107:3024-3029. [15]Park J, Welner RS, Chan MY, et al. The DNA ligase Ⅳ syndrome R278H mutation impairs B lymphopoiesis via error-prone nonhomologous end-joining[J]. J Immunol, 2016,196:244-255. [16]Altmann T, Gennery AR. DNA ligase Ⅳ syndrome: a review[J]. Orphanet J Rare Dis, 2016,11:137. [17]Plowman PN, Bridges BA, Arlett CF, et al. An instance of clinical radiation morbidity and cellular radiosensitivity, not associated with ataxia-telangiectasia[J]. Br J Radiol, 1990,63:624-628. [18]Yue J, Lu H, Lan S, et al. Identification of the DNA repair defects in a case of Dubowitz syndrome[J]. PLoS One, 2013,8:e54389. [19]Bacon CM, Wilkinson SJ, Spickett GP, et al. Epstein-Barr virus-independent diffuse large B-cell lymphoma in DNA ligase 4 deficiency[J]. J Allergy Clin Immunol, 2013,131:1237-1239. [20]Jing H, Zhang Q, Zhang Y, et al. Somatic reversion in dedicator of cytokinesis 8 immunodeficiency modulates disease phenotype[J]. J Allergy Clin Immunol, 2014,133:1667-1675. |